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Altered erythrocyte membrane protein composition 
mirrors pleiotropic effects of hypertension 
susceptibility genes and disease pathogenesis
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Olga Yu Bushueva3, and Maria A. Solodilova3
Objective: The study was designed to assess the effects of 
polymorphisms in genes associated with essential 
hypertension on the variation of erythrocyte membrane 
proteins (EMPs) in hypertensive patients.
Methods: Major EMPs content was analyzed in blood 
from 1162 unrelated Russians (235 hypertensive 
patients, 176 healthy controls, and 751 random 
individuals from the Central Russia population). Essential 
hypertension patients were genotyped for 11 
polymorphisms of essential hypertension susceptibility 
genes including A D D 1 (rs4961), GNB3 (rs5443, 
rs 16932941), N 0S3  (rs 1799983, rs2070744), A C E  
(rs5186), AGTR1  (rs5186), A G T  (rs699, rs4762), MR 
(rs5534), and TGFB1 (rs1800471). EMP contents and 
their relationship with the genetic loci were analyzed 
using various statistical tests.
Results: Sex-specific differences in EMP contents between 
the cases and controls were observed. Regardless of sex, 
hypertensives exhibited mainly decreased levels of alpha 
(SPTA1) and beta-spectrin (SPTB) and increased levels of 
glucose transporter (GLUT1) as compared with healthy 
subjects (P <  0.001). EMP correlated differently in essential 
hypertension patients and controls. Almost 70%  of the 
joint variation in the EMP levels is explained by five 
gender-specific principal components. The essential 
hypertension susceptibility genes showed considerable 
effects on the levels of spectrins and glucose transporter.
A  joint variation of the genes explained about half the 
total polygenic variance in the GLUT1, SPTA1, and SPTB 
levels in hypertensives.
Conclusions: The study showed that essential 
hypertension susceptibility genes are the important factors 
of the inherited EMP variation, and their pleitropic effects 
may be mirrored in the altered expression of genes 
encoding cytoskeletal proteins and those related to 
intracellular glucose metabolism.
Keywords: cytoskeleton, erythrocyte membrane proteins, 
essential hypertension, genetic polymorphism, genetic 
susceptibility, glucose metabolism, glucose transporter, 
molecular mechanisms, quantitative variation, spectrin
INTRODUCTION
H ypertension is a global public health  issue and is responsible for at least 45% o f deaths ow ing to heart disease and 51% of deaths ow ing to stroke [1]. 
The num ber of deaths attributable to hypertension rose 
from 7.6 to 9-4 million estim ated for a period betw een  2000 
and 2013 12,3]- H ypertension is know n to be a multifactorial 
disease arising from a com plex interplay betw een  multiple 
genetic and environm ental factors jointly contributing to 
disease susceptibility [4,5]. Despite decades of intensive 
basic and clinical research, intrinsic m echanism s underlying 
essential hypertension (essential hypertension), the com ­
m on form  o f hypertension, rem ain far from being com ­
pleted [6]. There is a substantial progress tow ard detection 
of genes underpinning distinct m olecular m echanism s of 
the disease [5,7,8], and w ide spectrum  of interm ediate 
phenotypes underlying high BP and essential hypertension 
has b een  identified [6,9]-
A num ber of studies have show n that alterations in 
structural and functional properties of the cell m em brane 
may represent disease-associated interm ediate phenotypes 
reflecting the particular m echanism s of essential hyperten­
sion [10-18]. An elevated erythrocyte Na+-Li+ countertran­
sport is one o f the best know n interm ediate phenotypes of 
the m em brane abnorm alities found in hypertensive 
hum ans and animals [19]. Further studies resulted in the 
discovery o f generalized structural and functional altera­
tions in erythrocyte m em brane m irrored the similar 
phenom enon  in o ther cell types in essential hypertension
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[20,21]. Functional alterations in Na+-Li+ countertransport 
and other m em brane ion transporters are thought to be 
responsible for abnorm al intracellular distribution of 
calcium ions required for contraction o f sm ooth muscle 
cells, leading to increased cytosolic free calcium and arterial 
contractility leading to hypertension [12,22,23]. These 
observations m ade erythrocytes an  attractable and biologi­
cally plausible m odel for studying the role o f m em brane 
alterations in the m olecular m echanism s o f hypertension
[12,14,24,25].
It is im portant to no te  that abnorm alities in ion  trans­
po rte rs’ functions are considered  as a genetically deter­
m ined feature o f prim ary hypertension, rather than  the 
consequence  o f long-term  elevation of BP [12,23]. The 
altered  activity o f m onovalent ion  transporters in essential 
hypertension, in contrast to m onogenic hypertensions, 
m ay be  because o f abnorm alities o f system s involved in 
the regulation  of their expression a n d /o r function [23]. 
Familial aggregation  and  higher concordance o f increased 
Na+-Li+ countertransport in m onozygotic tw ins than  in 
dizygotic tw ins suggest m ultifactorial nature o f m em brane 
disorders in essential hypertension  [24]. This m eans that 
the ion  transport abnorm alities of cell m em brane in 
essential hypertension  are attributable to the effects of 
m ultiple genes, w hich have the poten tia l to modify 
expression of genes w hose  products form  the structure 
o f the cell m em brane.
Num erous studies have show n that the intracellular 
distribution of m onovalent ions in hypertension is corre­
lated w ith alterations in protein com position o f the eryth­
rocyte m em brane [14,15,26-31]. Despite incredible 
advances in genom e research, a little concern so far is 
given to uncovering the pathogenetic link betw een  well 
characterized genetic determ inants of essential hyperten­
sion and altered properties of the cell m em brane. A lthough 
a large num ber of polym orphic genes w ere found to be 
associated w ith susceptibility to essential hypertension, no 
study has b een  done to investigate w hether these genes 
contribute to alterations in content o f cell m em brane 
proteins in the disease. Pursuing this interest, the present 
study was designed to test the hypothesis that alterations in 
the levels of erythrocyte m em brane proteins in essential 
hypertension are related to the effects of polym orphic 
genes associated w ith disease susceptibility.
M E T H O D S  
Study participants
The study was carried out in four stages (Fig. 1). A total of 
1162 unrelated individuals w ere involved into the study. All 
the participants w ere Russians from  Central Russia (pre­
dom inantly from Kursk region). The Ethical Review Com­
mittee of the Kursk State Medical University has approved 
the study protocol, and each participant signed inform ed 
consent at the recruitm ent. A random  sam ple of 751 (371 
males and  380 females) was enrolled to estimate the p o p u ­
lation m eans of the EMPs for statistical genetic analysis. The 
study group also included 235 patients w ith doctor-diag­
nosed essential hypertension and 176 healthy subjects w ith 
norm al BP. M ean age of essential hypertension patients 
(67 m en and 168 w om en) was 47.8 ± 9 -6  years, and the
m ean age o f the healthy subjects (75 m en and 132 w om en) 
w as 45-9 ± 1 1 .2  years. Patients w ith essential hypertension 
w ere recruited from  the Cardiology Clinics o f Kursk 
Regional Clinical Hospital and Kursk Em ergency Medicine 
Hospital betw een  2003 and 2007 [32]. Diagnosis of essential 
hypertension was verified by qualified cardiologists. 
Patients w ere defined as hypertensive according to the 
W orld Health Organization criteria. All these subjects 
underw ent bo th  m olecular genetic analysis for hyperten­
sion susceptibility genes and biochem ical investigations for 
erythrocyte m em brane proteins contents.
Molecular genetic analysis
O n the basis o f supportive peer-rev iew ed scientific p u b ­
lications, w e selected  genes involved in the regulation of 
vascular hom eostasis w ith a focus on  w ell recognized 
hypertension  susceptibility loci that have b een  reported  
to  be associated w ith  the risk o f essential hypertension  o r / 
and  w ith  the level o f BP in  Russian popu lations [33-38]. A 
total o f 11 single nucleotide polym orphism s (SNPs) of 
hypertension  susceptibility genes including transform ing 
grow th factor beta 1 (TGFB1) R25P (rsl800471), adducin  1 
(A D D !)  G460W (rs496l), guanine nucleotide-binding 
pro te in  beta po lypep tide 3 (G N B3) C825T (rs5443) and 
G272S (rsl693294l), nitric oxide synthase 3 (N O SJ) E298D 
(rsl799983) and  —78 6 T > C  (rs2070744), angiotensin  I- 
converting enzym e (ACE) I/D  (rs5186), angiotensin  II 
recep to r type 1 (AG TR1) A1166C (rs5186), angiotensino- 
gen  (AGE) M235T (rs699) and T174M (rs4762), m inera- 
locorticoid recep tor or nuclear recep to r subfam ily 3 group 
С m em ber 2 (N R3C 2) A4582C (rs5534) w ere selected for 
this study.
Approxim ately 5 ml of venous b lood  w ere collected 
from the patients in K3-EDTA tubes and genom ic DNA 
w as isolated by standard phenol-chloroform  extraction. 
Genetic polym orphism s w ere typed by  PCR-RFLP assays 
as described elsew here [33-35,39-44]. Each PCR reaction 
contained internal controls, and random  retesting of about 
10% o f sam ples resulted in a 100% concordance rate w ith 
initial genotyping data.
Biochemical analyses
Approximately 5 ml o f fasting w hole b lood samples w ere 
collected from each study participant in the morning. Eryth­
rocytes w ere precipitated from fresh heparinized w hole 
b lood  samples by  the m ethod o f Beutler e t al. [45]. Ghosts 
o f erythrocytes w ere prepared according to a modified 
m ethod described by D odge e t al. [46]. W ashed ghosts of 
erythrocytes w ere lyophilized, frozen, and stored at —20°C. 
Fractionation of major erythrocyte m em brane proteins was 
perfom ied by one-dim ensional SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) w ith gradient concentration 
5-25%  according to Laemmli’s m ethod [47]. The m em brane 
proteins w ere detected by  immunological m ethods as 
described elsew here [48] and classified accordingly as p ro ­
posed by Steck and Fairbanks e ta l. [49,50]. The identification 
and molecular weight calculations of red b lood cell proteins 
w ere perform ed using standards of protein markers as p re­
viously reported [48]. The levels o f erythrocyte m em brane 
proteins w ere quantified through know n concentration of
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Overview of the study pipeline
S T A G E  1: A n a ly s is  for 
d ifferences in erythrocyte 
m embrane protein contents 
between hypertensive and 
norm otensive ind iv id ua ls
Aim:
To compare major erythrocyte 
membrane protein (EM P)levels 
between hypertensive patients 
and healthy controls in entire 
and gender-stratified groups
Materials:
Russian patients with doctor- 
diagnosed essential 
hypertension (N =  234; 82 males 
and 152 females) and healthy 
subjects with normal blood 
pressure (N =  176; 75 males 
and 101 females) from 
Kursk regiotn.
S T A G E  2: Interrelations 
between erythrocyte 
m embrane protein levels in 
hypertensive patients and 
healthy su b jects
Aim:
T о measure the strength and 
direction of the linear 
relationship between the EMP 
levels in the study groups 
stratified by gender. To identify 
the integral factorsresponsible 
for the total variability of a 
complex of EM Ps in 
hypertensive males and females
Materials:
The EMP levels of the same 
patients investigated on 
S T  A G E  1 (234 EHpatients and 
176 healthy controls).
S T A G E  3: The relationship 
between hypertension 
suscep tib ility  gen es and 
erythrocyte membrane protein 
levels in the patients
Aim:
To analyzethe impact of 
polymorphismsin hypertension 
susceptibility genes on the 
EMP levels in hypertensive 
patients
Materials:
D N A  sam ples obtained from 
hypertensives who underwent 
biochemical investigations of 
EMP contents on S T A G E  1 
(N =  234); an independent 
population sample of Russian 
inhabitants from the Central 
Russia (N =  751; 371 males 
and 380 females)
S T  A G E  4: A  com prehensive 
contribution of hypertension 
susce p tib ility  genes to 
variability of erythrocyte 
m embrane proteins
Aim:
T о estimate the proportion of 
total phenotypic and polygenic 
variances ofthe EM Ps explained 
by the variation of hypertension 
susceptibility genes
Materials:
The biochemical and genotypic 
data of hypertensive patients 
obtained on S T A G E S  1-3 
(N =  234); the EMP levels of the 
population sample investigated 
on S T A G E  3 (N  =  751)
FIGURE 1 Overview of the study pipeline, initial analysis was done to establish differences in contents of 14 major erythrocyte membrane proteins (EMPs) between 
hypertensive and normotensive subjects (STAGE 1). Then, the strength and direction of alterations in the EMP levels were assessed and the integral factors explaining the 
joint variation of membrane proteins in essential hypertension patients were estimated (STAGE 2). Subsequently, the analysis of relationships between 11 common 
polymorphisms in hypertension susceptibility genes and EMP contents was carried out (STAGE 3) and the estimates of the proportion of total phenotypic and polygenic 
variances of the proteins explained by the variation of a group of the genetic loci were obtained (STAGE 4).
bovine serum  album in (|ag) using the program  ONE-Dscan 
(Scanalytics Inc., Fairfax, VA, USA).
Statistical analysis
The distribution o f the quantitative traits w as evaluated for 
norm ality by K olm ogorov-Sm irnov test. Differences in 
EMP contents betw een  the case and control groups w ere 
tested using modifications o f Student’s t  test for the traits 
w ith equal or unequal variances as required. The Brown- 
Forsythe’s test w as applied to assess the equality of EMP 
variances betw een  the groups [51]. A P  value <0.05 was 
considered significant. Pearson correlation coefficients 
w ere calculated to m easure the linear relationships 
betw een  the EMP levels in the study groups. The principal 
com ponent analysis w as applied to identify the integral 
factors responsible for the total variation of EMPs [52]. The 
varim ax-norm alized rotation was used  to simplify the 
interpretation o f the principal com ponents. Allele frequen­
cies for the polym orphism s w ere estim ated by the gene 
counting m ethod. Hardy-W einberg equilibrium  for geno­
type frequencies w as assessed by / 2 test. A one-w ay and 
tw o-w ay analysis of variance (ANOVA) was perform ed 
for the EMP levels to test the hypothesis that their p h en o ­
typic variation is affected by  the genetic polym orphism s 
alone and their com binations, respectively [53]. The coef­
ficient o f determ ination (P2) was used to evaluate the 
degree of relationship betw een  genetic polym orphism s 
and EMP levels.
The average effects o f the particular allele (a,, /= 1 ,  2) on 
EMP variability in hypertensive patients w ere estim ated 
using algorithms described in [54]:
_ / l l  ' Pl l  +  0-5 ' / 1 2  ' P i 2
h i  ' P 22 +  0.5 ' f _2 - P i2
w here f t is frequency of allele i; f tj  is the frequency of 
genotype ij expected  under the assum ption o f H ardy - 
W einberg equilibrium; /x,y is the average of the trait values 
for individuals w ith the genotype ij; fi is the estimate of the 
population  mean.
The variance attributable to genotypic differences was 
com puted as [54]:
Of У ' f  j ( pj j  /2 )~■
w here the values are sum m ed for each genotype of 
the locus.
The variance attributable to the average effects o f the 
alleles at the locus (additive genetic com ponent) was 
calculated as:
М =  2 ] Г / < 4
3
w here the values are sum m ed u p  for each allele of 
the locus.
The variance attributable to the nonadditive interactions 
(dom inant genetic com ponent) betw een  the alleles of the 
locus was calculated as:
D = G - A
Additive and dom inant com ponents of the variance 
attributable to a com plex of the loci w ere calculated as 
w eighted averages of the trait over all polym orphism s. A 
percentage of the average value of the genotypic variance 
attributable to the interloci variability to heritability (b 2) was 
considered as the contribution of genetic variance (Gpg) to 
the total polygenic variance of the traits. Estimates of EMP 
heritability w ere com puted in our previous study as a 
doubled  p a ren t-ch ild  correlation coefficients for each trait 
[55]. The statistical calculations w ere done using Statistica 
for W indows vlO.O (StatSoft; Tulsa, OK, USA) and Microsoft 
Excel 2007 (Microsoft Corp., USA).
R E S U L T S
Alterations in contents of erythrocyte 
membrane proteins in patients with essential 
hypertension
All erythrocyte m em brane proteins in the study subjects 
w ere norm ally distributed № > 0 .05 ). Table 1 show s a 
com parison of EMP levels betw een  patents w ith essential 
hypertension and healthy subjects. The increased levels of 
p rotein  band  4.1 (ЕРВ4Г), glucose transporter (GLUTl) and 
actin (ACTB), and  decreased levels o f a-spectrin  (SPTAl), 
(3-spectrin (SPTB), and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) w ere found in hypertensives as 
com pared w ith controls. Sex-stratified analysis revealed 
differences in the EMP levels betw een  males and females. 
The decreased SPTAl levels and increased GLUTl levels 
w ere found in hypertensive males in com parison with 
healthy controls. M eanwhile, the levels o f cytoskeletal 
proteins SPTAl, SPTB, dem atin (DMTN), and GAPDH were 
significantly low er in hypertensive females than in healthy 
females, w hereas the GLUTl and ACTB levels w ere higher 
in hypertensive then  in norm otensive females. Protein 
bands 2.1 (ankyrin 1, ANK1), anion exchanger (AEl), 
pallidin (EPB42), GLUTl, and GAPDH show ed differences 
in variances betw een  the study groups (Supplem entary 
Table 1, http://links.lww.com /HJH/A51T).
Joint variability of erythrocyte membrane 
proteins in hypertensive patients
Statistically significant correlations CP<0 .05) betw een  the 
levels of erythrocyte m em brane proteins w ere observed in 
bo th  hypertensive patients and healthy controls (Fig. 2). 
Notably, paired correlation coefficients betw een  EMPs, 
w hose contents w ere altered in hypertensives in com pari­
son w ith healthy subjects, show ed considerable differences 
betw een  the case and  control groups. Correlations betw een  
such EMPs in males and females w ere o f interest. For 
instance, SPTAl levels w ere negatively correlated w ith 
GAPDH contents in hypertensive females and healthy 
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Pairw ise correlation matrix of erythrocyte m embrane proteins in hypertensive patients and healthy contro ls stratified by gender
E M P s S P T A 1 S P T B A N K 1 .1 A N K 1 .2 A N K 1 .3 AE1 EPB41 EPB42 G L U T 1 D M T N A C T B G A P D H T P M 1 G S T M 1
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FIGURE 2  Pairwise correlation matrix of erythrocyte membrane proteins in hypertensive patients and healthy controls stratified by sex. Statistically significant correlation 
coefficients in hypertensive (numerator) and normotensive (denominator) males and females are shown above the central diagonal and below it, respectively. NS means a 
nonsignificant correlation coefficient.
females. The levels o f GLUT w ere positively correlated w ith 
EPB41 levels in healthy males, bu t no  such correlation was 
observed in hypertensive males.
Principal com ponents analysis w as applied  to the 
dataset to reduce the dim ensionality of a set of ery thro­
cyte m em brane pro teins and  to identify the integral 
factors responsible for their joint variability. A significant 
p roportion  o f the joint variation o f EMP levels (72.4% 
in m ales and  71.0% in fem ales) w as because o f the five
factors, w hich show ed  differences b e tw een  sexes 
(Table 2). In males, substantial loadings to the principal 
com ponen t 1 (PC I) (explained  27% o f total EMP var­
iance) appeared  for a majority o f EMPs such as an 
anchoring m em brane p ro tein  ankyrin (bands 2.1, 2.2, 
and 2.3), AE1, АСТВ, TPM1, and  m em brane-associated  
enzym es GAPDH and  m em brane-associated  GSTM1. In 
females, the PCI (explained 24% o f total EMP variance) 
had substantial loadings only for ankyrin, actin,
TA BLE 2. Principal com ponents analysis o f erythrocyte m em brane proteins levels in patents w ith  essential hypertension
Males Females
M em brane proteins PC1 PC2 PC3 PC4 PC5 PC1 PC2 PC3 PC4 PC5
SPTA1 -0 .1 8 9 -0 .6 9 2 -0 .5 0 0 -0 .109 -0 .0 4 9 -0 .3 6 3 -0 .7 5 0 0.276 0.125 -0 .0 4 8
SPTB -0 .1 8 3 -0.751 0.032 -0.149 0.112 -0 .315 -0 .8 0 0 0.113 0.066 -0 .263
ANK1.1 -0.711 0.089 0.139 -0 .277  0.178 -0.71 1 0.016 -0.141 0.179 -0 .365
ANK1.2 -0 .676 0.124 0.384 0.122 0.440 -0 .715 0.332 -0 .383 -0 .110 -0 .0 7 6
ANK1.3 -0 .7 2 3 0.256 0.450 0.030 0.204 -0 .7 1 7 0.303 -0 .3 2 8 -0 .205 -0 .0 7 3
AE1 -0.601 -0 .297 -0 .272 0.134 -0.115 -0 .3 1 6 -0 .017 0.059 0.117 0.875
EPB41 -0 .5 0 9 0.472 -0 .1 4 8 0.108 -0 .4 4 9 -0 .3 5 3 0.467 0.361 0.005 -0 .0 2 9
EPB42 -0 .576 -0 .0 5 6 0.133 0.600 -0 .158 -0 .3 4 9 0.214 0.357 -0.643 0.006
GLUT1 0.396 0.819 -0 .0 4 4 -0 .124 -0 .0 6 8 0.362 0.774 -0 .0 8 4 0.114 -0.071
DMTN 0.171 -0 .365 0.559 0.201 -0 .520 0.096 -0 .227 0.111 -0 .798 0.095
ACTB 0.501 0.250 -0 .4 2 4 0.437 0.348 0.317 0.315 0.638 0.306 -0 .0 9 7
GAPDH 0.467 -0 .1 5 4 0.178 0.596 0.123 0.572 0.047 0.254 -0.311 -0 .252
TPM1 0.566 0.010 0.540 -0 .258 -0 .1 1 0 0.642 0.005 -0 .4 8 0 -0 .0 9 9 -0.111
GSTM1 0.552 -0 .412 0.323 0.006 0.255 0.540 -0 .393 -0.411 -0.071 0.118
Eigen values of principal components 3.785 2.506 1.657 1.185 1.009 3.379 2.575 1.515 1.388 1.096
The percentage of total variance 
explained by the respective 
number of factors
27.0 17.9 11.8 8.5 7.2 24.1 18.4 10.8 9.9 7.8
Gray cells represent factor loadings with a value >±0 .500 ,  a threshold selected for inclusion of the trait in the interpretation of principal components.
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tropom yosin, and  GSTM1. The PC2 (responsible for 
alm ost 18% o f total EMP variance) show ed  substantial 
factor loadings for m ajor cytoskeletal proteins such as 
spectrin  and  p ro tein  4.1, and  also GLUT1 in b o th  sexes 
and  additionally for GSTM1 in males. The PC3 differed 
substantially b e tw een  m ales and  females. In m ales, the 
PC3 had  substantial loadings for SPTA1, SPTB, ankyrin 
(band  2.3), DMTN, ACTB, and  TPM1. In females, the PC3 
w as only associated w ith  the variability of ACTB, TPM1, 
and  GSTM1. The rest tw o principal com ponents w ere 
responsible for only 15% and  17% of total EMP variance 
in m ales and  females, respectively.
The average effects of alleles of hypertension 
susceptibility genes on the levels of 
erythrocyte membrane proteins
We estimated average effects o f alleles on  the levels of EMT in 
the hypertensives using m ethodology proposed  by  Sing and 
Davignon [54]. To calculate the average effects, w e used 
population m eans for each EMP estim ated in a population 
sample of Russians (Supplem entary Table 2, http://link- 
s.lww.com/HJH/A511) and the frequencies of alleles of 
disease susceptibility genes in hypertensives (Supple­
m entary Table 3, http://links.lww.com/HJH/A51T). 
Figure 3 show s a graphical representation o f the average 
effects o f alleles on  the EMP levels for genes associated with 
hypertension in our population (the average effects of alleles 
for other loci are given in Supplem entary Figure 1, h ttp :// 
links.lww.com/HJH/A51T). As expected, allelic variants of 
almost all of the investigated genes influence, though in 
varying degrees, the contents of EMP in hypertensive 
patients. In most cases, the average effects o f alleles on 
the EMP levels w ere m oderate, and  the direction o f devi­
ations of the trait from the population m ean was mutually 
inverted in the carriers o f alternative alleles. Furthermore, the 
effects o f alleles on  the EMP levels w ere unequal in males and 
females. In particular, the 460W allele o f the AD D 1  gene 
influenced the levels o f spectrins, ankyrin 2.1, GLUT1, 
DMTN, and GSTM1 in males, and SPTA1, SPTB, ankyrin 
2.2, AE1, GLUT1, ACTB, GAPDH, and GSTM1 in females. 
Notably, the effects o f the allele 460W on  the EMP contents 
w ere in opposite directions in hypertensive males and 
females; the allele increased the level o f GLUT1 and was 
associated w ith a lower SPTA1 and SPTB in males, w hereas in 
females, the allele decreased GLUT1 content and increased 
the levels of the spectrins. Higher effects on  contents of 
GLUT1, SPTA1, and SPTB in females w ere seen for the 272S 
allele o f the GNB3 gene. The 25P allele o f the TGFB1 gene 
exhibited similar effects on  GLUT1, SPTA1, and SPTB con­
tents in bo th  sexes, similarly to those found in males w ith the 
460W allele. In males, the effects of the HGT235 M allele on 
the levels o f GLUTand spectrins w ere com parable w ith the 
effects o f the AD D 1  460W allele.
The contribution of the studied genes to 
quantitative variability of erythrocyte 
membrane proteins in hypertensive patients
Using ANOVA, w e assessed the im pact of hypertension  
susceptibility genes on  the EMP levels in  fem ale and  m ale 
patients (Fig. 4). Notew orthy, the EMPs, w hose contents
w ere changed in hypertensive patients in com parison  w ith 
healthy  controls, w ere associated w ith com binations of 
hypertension  susceptibility genes. In particular, a com bi­
nation  o f the G NB3  C825T and  HGTT174 M polym orphism s 
explained  24.3% CP=0.01) o f the total variation o f SPTB 
and  17.6% ( p  =  0.04) o f GLUT variation in  males. The A G T  
M235T and  A G T R 1 1166A/C loci w ere responsible for 
21.2% ( p  =  0.01) o f SPTB variation, w hereas a com bination 
ofMGTM235T w ith the N O S3  E298D locus was responsible 
for 13-3% (P =  0.05) o f the total variance o f this cytoskeletal 
p ro te in  in males. In females, the A D D 1  G460W and NO S3  
E298D gene polym orphism s explained  7.4% CP=0.04) of 
the total variation o f SPTA1 and  11.0% C P=0.01) o f SPTB 
variation, w hereas a com bination  o f the A G T R 1 1166A/C и 
GNB3  G814S loci w as responsible for 7.5% C P=0.02) of 
SPTB variation. M oreover, com binations of the polym or­
phism s GNB3  C825T and  G NB3  G814S, GNB3  C825T and 
N O S3  E298D, G NB3  G814S and  N O S3  E298D in fem ales 
explained  o n  average from  5% to 9% o f the variation of 
EMPs w hose contents w ere altered  in hypertensive patients 
(SPTA1, SPTB, and  GLUT1).
As essential hypertension  is a com plex polygenic dis­
ease, there is a need  for a com prehensive analysis w here 
m ultiple genetic polym orphism s are evaluated sim ul­
taneously  regarding their joint contribu tion  to the varia­
bility o f EMPs in hypertensive individuals. Therefore, w e 
used  m ethodology  described by Sing and  D avignon [54] to 
estim ate the sum m ary contribution  o f disease susceptibility 
genes to the variation o f erythrocyte m em brane proteins in 
hypertensive patients (Table 3; Supplem entary Tables 4 
and  5, http://links.lw w .com /H JH /A 51T). The total genetic 
variance (G) associated w ith  the studied genes ranges from
3.1 (DMTN) to 47.6% (GLUTT) in  males, and  from  1.1 
(DMTN) to 27% (SPTAT) in females. Notably, the highest 
im pact o f the genetic variation w as found on  the variation 
o f SPTA1 (24.4% in m ales and  27% in fem ales) and SPTB 
(29.4% in m ales and  23.2% in fem ales) and  also integral 
m em brane pro teins such as AE1 (36.8% in m ales and  12% in 
fem ales) and  GLUT1 (47.6% in m ales and  23.1% in 
fem ales). Taking into account heritability for SPTA1 
(52%) and  SPTB (60%) [55], the studied  genes w ere esti­
m ated to be  responsible for as m uch as 47 and  49% o f their 
total polygenic variances in m ales and  50 and  39% in 
females. M oreover, these loci m ay also be  responsible 
for as m uch as 64 and  31% o f the total polygenic variance 
o f GLUT in m ales and  females, respectively.
D IS C U S S IO N  
Alterations in the levels of erythrocyte 
membrane proteins and their joint variation in 
essential hypertension
Consistently w ith previous studies [12,27,55,56], w e dem ­
onstrated that essential hypertension is accom panied by 
alterations in the com position of major erythrocyte m em ­
brane proteins. In particular, hypertensive patients exhib­
ited increased levels of protein 4.1, glucose transporter, and 
actin and also decreased levels o f a  and SPTB and GAPDH. 
Two independent studies conducted  on  Russian families 
from Kursk region [55,56] show ed similar alterations in 
integral and peripheral m em brane proteins (AE1, ACTB,
6
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FIGURE 3 The average effects of alleles in hypertension susceptibility genes on the levels of erythrocyte membrane proteins in hypertensive patients. Line charts represent 
the average effects of major (blue lines) and minor (red lines) alleles on EMP variability, that is, a deviation of the trait from the population mean (jx) in hypertensive males 
(left charts) and females (right charts). Pleiotropic and sex-specific effects on the EMPs levels were noted for several hypertension susceptibility genes. For instance, the 
overall effect of the 460W  A D D  1 allele was to decrease of the SPTA1 and SPTB levels and to increase of the content of GLUT1 in hypertensive males, whereas in 
hypertensive females the 460W  allele associated with an increase of both spectrins and decrease of GLUT1.
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| Pairwise interactions between gene polymorphisms I > impact of gene polymorphisms on protein levels
FIGURE 4  The effects of pairwise combinations of hypertension susceptibility genes on the levels of erythrocyte membrane proteins in hypertensive patients. The figure 
shows the significant effects (P <  0.05) of pairwise combinations of the genetic polymorphisms on the EMP levels in hypertensive females (left part) and males (right part). 
The estimates were performed by two-way ANOVA and expressed as R2 values, which varied between 10 and 2 6 %  in males, and between 6 and 11 %  in females. The 
free yEd graph editor was used to draw the figure.
EPB41, and  DMTN) and  proteins related to glucose m etab­
olism (GLUT1 and GAPDH) in patients w ith essential hy­
pertension. Similarly, in a sam ple of Russian hypertensives 
from Moscow, alterations in GLUT1 and GAPDH levels in 
essential hypertension patients in com parison w ith healthy 
subjects have b een  also observed [27]. Furtherm ore, the 
present study dem onstrated for the first time sex-specific
alterations in major erythrocyte m em brane proteins in 
hypertensive patients. A lthough similar alterations in the 
levels o f spectrins and GLUT w ere found in bo th  sexes, 
hypertensive females also exhibited decreased levels of 
DMTN and GAPDH in com bination w ith increased levels 
o f ACTB. Thus, patients w ith essential hypertension dem ­
onstrate altered expression an d /o r posttranslational
TA BLE 3. The percentage o f total phenotypic and genetic variances o f the EMPs explained by a com prehensive contribution o f disease  
__________susceptib ility  genes in hypertensive patients_________________________________________________________________________________




SPTA1 SPTB AN K1 (1) AN K1 (2) ANK1 (3) AE1 EPB41 EPB42 GLUT1 DMTN ACTB GAPDH TPM1 GSTM1
Males G 24.35 29.39 6 .86 4 .26 1.90 36.82 4 .02 4 .43 47 .55 3 .08 4 .59 4 .55 12.07 10.29
A 15.62 20.44 4.94 2.65 1.24 17.23 2.25 3.02 33.03 1.55 2.40 2.74 5.76 6.21
D 8.73 8.95 1.92 1.61 0.66 19.60 1.77 1.41 14.51 1.53 2.19 1.81 6.31 4.08
Gpg 47 .20 49 .22 9.33 6 .59 7 .24 41 .7 5 4 .52 23 .18 64.43 3 .85 9 .34 5.62 16.33 20 .57
Females G 26.99 23.20 1.79 1.85 0.71 12.02 0.99 2 .56 23 .12 1.11 1.79 2.21 2 .65 3 .70
A 20.20 19.07 1.00 1.05 0.44 6.94 0.57 1.59 15.56 0.45 1.25 1.70 0.57 2.08
D 6.79 4.13 0.79 0.80 0.26 5.08 0.42 0.97 7.57 0.66 0.54 0.51 2.09 1.62
Gpg 50.31 38.87 2 .4 4 2 .87 2.69 13.63 1.11 13.42 31.33 1.39 3 .64 2.73 3.59 7 .39
h2, % 51.6 59.7 73.5 64.6 26.2 88.2 88.9 19.1 73.8 79.9 49.1 80.9 73.9 50.0
G (bold face values in white cells) denotes the percentage of total variance of the traits attributable to genotypic differences of the locus; A and D denote additive and dominant 
components of the G, respectively; Gpg (bold face values in gray cells) denotes the percentage of genotypic variance, attributable to differences between the loci, to the total polygenic 
variance of the traits; h2 denotes heritability of the traits computed as doubled parent-child correlation coefficients for each trait in our previous study [55]. EMP, erythrocyte membrane 
protein; DMTN, dematin actin binding protein; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GLUT1, glucose transporter 1; SPTA1, a-spectrin; SPTB, (3-spectrin.
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modifications of genes encoding cytoskeletal proteins and 
proteins directly involved in glucose metabolism.
Altered levels of erythrocyte m em brane proteins in 
essential hypertension  patients are correlated  to each  o t­
her, suggesting com m on sources of their co-variations, that 
is, shared  m olecular m echanism s underly ing the regulation 
o f expression  of the corresponding  genes. Principal com ­
ponen ts analysis identified several integral factors o f joint 
variability o f EMPs in hypertensives. The first factor mainly 
influenced by  AE1, EPB41, EPB42, ACTB, TPM1, GAPDH, 
and GSTM1 reflecting b o th  spatial and  functional coupling 
o f these pro teins localized in the inner half o f the plasm a 
m em brane. Based on  the results o f biochem ical studies 
show ed  that the cytoplasm ic dom ain  o f an ion  exchanger 
constitutes a m ajor m ultiprotein  com plex responsible for 
erythrocyte m em brane-peripheral p ro te in  interactions and 
attachm ent of the spectrin-actin  netw ork  and  cytoskeletal 
p roteins EPB41, EPB42, and  TPM1 to the inner surface of 
the m em brane via anchoring pro te in  ankyrin, w e assum e 
that this principal com ponen t m ay represen t a fac to r of 
m em brane-anchoring  pro te in  assem bly’ [57-591. The m ul­
tifunctional dom ain  o f AE1 is also a single b inding site for
GSTM1, GAPDH, and  o ther glycolytic enzym es, providing 
the enzym atic bridge to cytoskeletal proteins and  ion 
transport ATPases [60,61]. The second principal com ­
po n en t w ith the h ighest loadings for a  and  (3-subunits of 
spectrin  and  GLUT m ay represen t m ajor alterations in the 
EMP com position  found in hypertensives. In general, the 
results ob tained  by  PCA confirm ed that alterations in the 
levels o f particular erythrocyte m em brane pro teins in 
essential hypertension  patients are closely correlated  to 
each  o ther form ing distinct g roups of jointly varying 
proteins, w hich could be  attributable to p leitropic effects 
o f different polygenic systems.
Possible relationship between altered protein 
composition of erythrocyte membrane and 
pathogenesis of essential hypertension
In Fig. 5, w e sum m arized possible m echanism s through 
w hich alterations in the conten t o f EMPs can be  related 
to the pathogenesis o f essential hypertension. It is w ell 
know n that alterations in the levels o f the cytoskeletal 
proteins such as spectrins, actin, p ro te in  bands 4.1 and  4.9
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FIGURE 5 Possible molecular mechanisms by which alterations in contents of erythrocyte membrane proteins are involved in the pathogenesis of essential hypertension. 
The upper left gray box summarizes possible consequences of altered cytoskeletal protein contents in hypertensive patients and their relation to disease phenotypes. The 
lower left gray box summarizes proposed mechanisms by which membrane proteins related to intracellular glucose metabolism contribute to the development of 
hypertension. The right gray box represents well characterized mechanisms of essential hypertension [9,62]. Colored blocks indicate membrane proteins showed alterations 
in hypertensive patients: blue blocks indicate proteins altered only in both sexes, whereas pink blocks indicate proteins altered exclusively in females. Blue arrows indicate a 
decreased protein level, whereas red arrows indicate an increased protein level. The middle blocks indicate hypertension susceptibility genes influenced alterations in EMP 
contents in hypertensive males (M, numerator) and females (F, denominator). The dotted lines indicate pathogenetic links between altered contents of erythrocyte 
membrane proteins and the mechanisms of essential hypertension. See text for more details. ACE, angiotensin i-converting enzyme; ACTB, actin; AD D 1, alpha-adducin; 
AGT, angiotensinogen; AGTR1, angiotensin ii receptor type 1; DMTN, dematin (actin-binding protein); EPB41, erythrocyte membrane protein band 4.1; GAPDH, giyceralde- 
hyde-3-phosphate dehydrogenase; GLUT1, glucose transporter 1; GNB3, guanine nucleotide-binding protein beta polypeptide 3; Hb, hemoglobin; MR, mineralocorticoid 
receptor; NO, nitric oxide; N 0S3, nitric oxide synthase 3; ROS, reactive oxygen species; SPTA1, a-spectrin; SPTB, (3-spectrin; TGFB1, transforming growth factor beta 1.
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affect rheological p roperties o f red  b lood  cells th rough the 
changes in  the cytoskeletal architecture 158,63]- First, 
rearrangem ent o f cytoskeletal p roteins has a considerable 
im pact on  erythrocyte deform ity increasing blood  
viscosity, w hich  w as found  to affect vascular b lood  flow 
and  exacerbate m icrocirculatory disorders in  hyperten ­
sion [64]. Notably, the increased m em brane m icroviscosity 
in hypertensives is accom panied  by altered  kinetics of 
sodium -lithium  coun tertransport [65], w hich is a m ajor ion 
transport abnorm ality  in essential hypertension. Second, 
rearrangem ent o f cytoskeletal pro teins influences the 
ability o f intracellular hem oglobin  to release oxygen lead­
ing to tissue hypoxia, as it has b een  show n in hypertensive 
patients [18]. Third, abnorm al ratio b e tw een  spectrins, 
actin, p ro te in  4.1, and  dem atin  may im pair signaling p a th ­
ways coupling extracellular regulatory stimuli to the 
cytoskeleton th rough spatial discoordination betw een  
receptors and channels involved into the regulation of 
m em brane transport and  signal transduction. Lastly, an  
alteration in the p ro tein  com position  o f the m em brane 
cytoskeleton has the ability to influence the functioning of 
the ion  transport ATPases o f the m em brane through 
conform ational m odifications o f their active centers 
[58,66,67]. Animal studies show ed  that a rem oval o f spec­
trin from  erythrocytes results in tw o and  three-fold 
decreasing in  the activity o f Na+KTATPase and  Ca2+- 
ATPase, respectively [66,68], poin ting  ou t that reduced  
levels o f spectrins has the potential to influence the 
activity of transport ATPases, a possible m echanism  
involved into the ion transport abnorm alities in hum an 
hypertension  [13,23,24].
The present study revealed that the proteins directly 
involved in glucose m etabolism  such as GLUT and glyco­
lytic enzym e GAPDH w ere also significantly altered in 
hypertensive patients com pared w ith healthy subjects. 
Abnormal glucose m etabolism  is a w ell characterized dis­
order found in essential hypertension [69,70]. Figure 5 
show s potential m echanism s by  w hich GLUT1 and GAPDH 
may contribute to the developm ent of hypertension. Glu­
cose transporter is a type III integral m em brane protein  that 
facilitates the transport of glucose over a plasm a m em brane 
and maintains the low  level of basal glucose uptake 
required to sustain respiration in the cell [71]. As expression 
levels of GLUT1 in cell m em branes are increased by 
reduced glucose levels [72], our finding o f the increased 
GLUT1 levels in hypertensives may be  attributable to the 
reduced glucose influx w ithin the cell ow ing to insulin 
resistance in patients [73]- GAPDH is a m em brane-bound 
enzym e catalyzing an  im portant energy-yielding step  in the 
glycolytic b reakdow n of glucose [74]. It is im portant to 
notify that the enzym e in erythrocytes represents an  im port­
ant part of the glycolytic machinery, w hich com partm en­
talizes ATP, allowing its direct consum ption by  ion pum ps 
and transporters [75]. Perhaps the changes in the GLUT1 
levels in hypertensives reflect the need  of cells in a higher 
glucose up take and ATP production. This assum ption 
seem s attractive in the light of the hypothesis that the cause 
of elevated BP in chronic arterial hypertension is con­
sidered to be a com pensatory response to decreased ATP 
biosynthesis [76]. It was suggested that intracellular Ca2+ 
overload in hypertension can be a consequence of
augm ented ion perm eability of the plasm a m em brane 
an d /o r decreased Ca2+-ATPase activity because of partial 
ATP depletion [76]. These authors proposed  that an  atte­
nuated  intracellular ATP content enhances the stimulation 
o f sym pathic nerve system m aintaining long-term  elevation 
o f BP. Thus, changes in expression levels o f the GLUT1 and 
GAPDH genes in hypertensive patients m ay represent a part 
o f insulin-m ediated systemic im pairm ent of glucose dis­
posal in peripheral tissues, accom panied by decreased 
glucose uptake and  utilization by the cells [70,73,77].
A summary effect of the genes on the variation 
of erythrocyte membrane proteins in patients 
with essential hypertension
We revealed that hypertension  susceptibility genes con­
tribute to the variation o f erythrocyte m em brane proteins 
in  our patients. The strength  o f these effects w as quite 
substantial (individual R 2 values varied b e tw een  6 and 
24% in b o th  sexes), indicating that the genes are the 
im portant factors o f the inherited  variation of EMP co n ­
tents in hypertensives. This m eans that pleio tropic effects 
o f these genes are not lim ited by  the regulation o f vascular 
tone, sodium , and  w ater hom eostasis, bu t also influence 
the m anifestation o f genes expressed  in erythroid tissue. 
G enes associated w ith the risk o f essential hypertension  
such as A D D 1, AG T, AG TR1, GNB3, and  TGFB1 exhibited 
considerable effects o n  the levels o f m em brane proteins in 
hypertensive patients. In particular, com bination of GNB3  
C825T and  A G T  T174M gene polym orphism s show ed 
highest contribution to the variation o f SPTB (24%) and 
GLUT1 (18%) levels in m ale patients. The studied  genes 
account for abou t half the total polygenic variance of 
GLUT1, SPTA1, and  SPTB levels in  b o th  hypertensive 
m ales and  females. U ndoubtedly, the effects o f genes 
o n  the EMP variation can overlap. As it has b een  found 
in  our previous study [55], abou t 5-10%  o f the total 
variance o f spectrins and  GLUT as w ell as 95% of varia­
bility in the levels o f GLUT and  p ro tein  b and  4.1 in 
hypertensives (bo th  proteins w ere increased in essential 
hypertension  patients in com parison w ith controls) w ere 
explained  by  com m on underly ing genes.
Finally, the results o f our study are in line w ith findings 
observed by genetic m apping studies on  the animal m odel 
o f hum an hypertension. The com parative genom e m ap­
ping allow ed identifying the hom ologous chrom osom al 
regions in rats and hum ans. In particular, the long piece 
o f the hum an chrom osom al region lp34-p ter corresponds 
to the rat locus 5(a)-5(b) [23]. The 5(a) region contains 
quantitative trait locus (QTL) for elevated SBP in spon­
taneously hypertensive rats and includes the Glutb gene 
[78], a rat hom ologue of hum an glucose transporter. In 
addition, in Dahl S rats, GLUT gene is located in the QTL 
that has also b een  reported  to со-segregate w ith SBP [79] ■ 
Interestingly, except for GLUT1 located in a lp34.2, a 
hom ologous region at hum an chrom osom e lp  contains 
or is nearby the loci for a-spectrin  (lq21) and protein  band
4.1 (Ip33-p32), w hose altered contents in essential hyper­
tension may be  related to the pleitropic effect o f putative 
hom ologous QTL in hypertensive men. Moreover, another 
QTL identified in chrom osom e 2(a) is responsible for
10
increased BP in spontaneously hypertensive rats [80] and 
includes subunits o f Na+-K+ pum p and  Sptal, a rat hom- 
ologue of hum an SPTA1.
The present study has several limitations. We cannot 
exclude the possibility that changes in the levels o f the EMPs 
in hypertension may be related w ith oxidative dam age o f the 
m em brane due to increased production o f reactive oxygen 
species and decreased antioxidant activity, the m echanisms 
that are im portant in hypertension pathogenesis [81—83] ■ 
Some caution in interpretation of the data on  genotype- 
phenotype relationships is w arranted because not all 
possible gene polym orphism s have b een  investigated and 
none o f the param eters representing abnom ial ion transport 
o f red blood  cell m em brane have been  analyzed.
To the best o f our know ledge, this is the first study in 
w hich a sum m ary contribution of disease susceptibility 
genes to alterations in contents o f EMPs has b een  estim ated 
in hypertension. O ur study results extent and provide 
further support to the hypothesis that abnorm alities in 
m em brane structure and function represent an  im portant 
part o f hypertension pathogenesis. Rethinking the hypoth­
esis of ‘cell m em brane alteration as a source o f prim ary 
hypertension’ [12], w e can highlight that alterations in the 
levels o f EMPs is not a causative factor o f essential hyper­
tension p e r  se, bu t is rather a mirror of the multilevel (from 
organs to the cell) and multisystem (from a particular cell to 
various cell types/tissues) disorders related to the disease 
m echanisms. A better understanding of a nature of cell 
m em brane disorders and their pathogenetic link w ith hy­
pertension will contribute to a discovery o f clinically useful 
biological markers and targets for the developm ent of 
innovative drugs for m anagem ent and  prevention of 
the disease.
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